Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |